Although GDF15 serum levels seem to provide a better prediction of mitochondrial disease regardless of clinical phenotype (with a diagnostic sensitivity of around 80% [28,29,30]), the small number of patients evaluated in our series prevents us from drawing conclusions about its diagnostic performance in patients with PEO syndrome. The gene discussed is GDF15; the disease is mitochondrial disease.